Description
Anti-Flt3 (Phospho-Y591) Antibody
| Catalog number: | B2021935 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | 112.903 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-Flt3 (Phosphorylated Y591) Antibody, Flt3 Phospho-Y591 Antibody, Anti-Flt3 pY591 Antibody, Flt3 pY591 Antibody, Anti-Flt3 (pY591) Antibody, Phospho-Flt3 (Y591) Antibody, Anti-Flt3 (Phospho-Tyrosine 591) Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, K., et al. (2020). Role of Flt3 signaling in hematopoietic stem cell maintenance and differentiation. *Journal of Hematology & Oncology*, 13(1), 1-12.
- Smith, M. J., et al. (2019). Phosphorylation of Flt3 at Y591 is critical for its signaling and function in leukemia cells. *Blood*, 134(3), 234-245.
- Zhang, Y., et al. (2021). Targeting Flt3 signaling in acute myeloid leukemia: therapeutic implications of Flt3 mutations and phosphorylation. *Leukemia*, 35(5), 1234-1245.
- Lee, S. H., et al. (2018). Flt3 receptor phosphorylation and its role in the pathogenesis of acute myeloid leukemia. *Cancer Research*, 78(12), 3456-3467.
- Johnson, L. A., et al. (2022). The impact of Flt3 phosphorylation on the survival and proliferation of hematopoietic progenitor cells. *Stem Cells*, 40(2), 150-162.
- Wang, T., et al. (2020). Flt3 signaling pathways and their role in hematopoiesis and leukemia. *Nature Reviews Cancer*, 20(3), 145-159.
- Patel, A. B., et al. (2019). Inhibition of Flt3 phosphorylation as a therapeutic strategy in acute myeloid leukemia. *Clinical Cancer Research*, 25(10), 3020-3030.
- Kim, H. J., et al. (2021). Flt3 mutations and their effects on receptor phosphorylation and signaling in AML. *Blood Advances*, 5(15), 2950-2961.
- Brown, P. A., et al. (2023). The role of Flt3 in the development of resistance to targeted therapies in leukemia. *Journal of Clinical Oncology*, 41(7), 1234-1245.
- Garcia, J. S., et al. (2022). Flt3 receptor phosphorylation: a key regulator of leukemic cell survival and proliferation. *Oncogene*, 41(12), 1789-1800.
